Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Stretch-activated ion channels and transient receptor potential (TRP) ion channels are two overlapping families of membrane proteins that form cation-permeable pores activated by physical or chemical stimuli. **Stretch-activated ion channels (SACs)**, also called mechanosensitive or mechanogated channels, transduce mechanical forces (such as stretch, pressure, or osmotic changes) directly into electrical or biochemical signals by opening in response to deformation of the lipid bilayer or associated cytoskeletal structures[1][6][8]. **TRP ion channels** are a large, evolutionarily conserved superfamily of cation channels found throughout the animal kingdom and are involved in sensory processes such as touch, temperature, pain, taste, vision, and osmotic regulation[2][3][4][5][7]. Several TRP family members (especially TRPV4, TRPC1, TRPA1, and others) are mechanosensitive and thus can function as stretch-activated channels[5]. These channels regulate “second messengers” such as calcium ions and are implicated in various physiological and pathological processes, including cardiovascular, neuronal, renal, and inflammatory diseases[2][3][5]. Both SACs and TRP channels are considered promising but therapeutically challenging drug targets, due to their wide distribution and fundamental roles in multiple cell types[2][3][6]. Note: This entry describes two related but not identical classes of ion channels. Stretch-activated ion channels may encompass TRP family members but are not specific to any one protein, and “TRP ion channels” refers to a multigene superfamily with both mechanosensitive and other subtypes. For more structured drug or disease association, focus should be placed on a specific channel subtype (e.g., TRPV4, TRPA1).
Blockade or activation of channel to modulate ion flux; Allosteric modulation of gating (via ligands or peptides); Alteration of mechanosensitivity or ligand binding properties
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Stretch-activated ion channel and transient receptor potential ion channel (SAC and TRP channel).